1746
J. Kuszmann et al. / Carbohydrate Research 340 (2005) 1739–1749
1.17. 2,5-Anhydro-3-O-(-a-D-arabinopyranosyl)-D-
mannitol(18)
1,6,60,600). Anal. Calcd for C18H22O35S10K10: C, 12.95;
H, 1.33; S, 19.20; K, 23.41. Found: C, 12.48; H, 1.65;
S, 18.95; K, 23.08.
Deacylation of 17 (8.4 g, 11.5 mmol) was carried out as
described for the L-isomer 14 to give 18 (3.1 g, 91%) as
an amorphous powder; [a]D +7 (c 1, water). Anal. Calcd
for C11H20O9: C, 44.59; H, 6.80. Found: C, 44.42; H,
6.95.
1.22. 2,5-Anhydro-1,6-di-O-benzoyl-3-O-(heptaacetyl-b-
gentiobiosyl)-D-mannitol(25)
Prepared according to the general procedure A from 4
(2.6 g, 7 mmol) and 24 (4.7 g, 6.5 mmol) to give 25
(2.2 g, 32%); mp 166–168 ꢁC (EtOH), [a]D +9 (c 1,
CHCl3). Anal. Calcd for C46H54O240: C, 55.76; H,
5.49. Found: C, 55.79; H, 5.51.
1.18. 2,5-Anhydro-1,4,6-tri-O-sulfato-3-O-(2,3,4-tri-
O-sulfato-a-D-arabinopyranosyl)-D-mannitolhexa
potassium salt (19)
Sulfation of 18 (0.59 g, 0.3 mmol) was carried out as de-
scribed for the L-isomer 15 to give 19 (1.8 g, 90%); [a]D
1.23. 2,5-Anhydro-3-O-(b-gentiobiosyl)-D-mannitol(26)
1
+21 (c 1, water); H NMR: d 5.02 (m, 1H, H-10), 4.90–
Prepared according to the general procedure B from 25
(2.0 g, 1.87 mmol) to give 26 (0.95 g, ꢀ100%) as
amorphous powder, [a]D +7 (c 1, water). Anal. Calcd
for C18H32O15: C, 44.26; H, 6.60. Found: C, 44.14; H,
6.85.
4.78 (m, 2H, H-40,40), 4.75 (m, 1H, H-20), 4.60–4.55 (m,
2H, H-5,30), 4.52 (m, 1H, H-3), 4.42 (m, 1H H-20), 4.32–
4.15 (m, 4H, H-1a,1b,6a,6b), 4.12 (m, 1H, H-5a0), 3.78
13
(m, 1H, H-5b0); C NMR: d 100.8 (C-10), 84.8 (C-4),
84.2 (C-5), 84.1 (C-3), 82.8 (C-2), 76.6 (C-30), 76.3 (C-
20), 74.2 (C-40), 69.7 (C-6), 69.3 (C-1), 62.5 (C-50). Anal.
Calcd for C11H14O27S6K6: C, 13.14; H, 1.40; S, 19.14; K,
23.34. Found: C, 13.00; H, 1.69; S, 18.63; K, 23.21.
1.24. 2,5-Anhydro-1,4,6-tri-O-sulfato-3-O-[6-O-(2,3,4,6-
tetra-O-sulfato-a-D-glucopyranosyl)-2,3,4-tri-O-sulfato-
b-D-glucopyranosyl]-D-mannitoldeca potassium satl (27)
1.19. 2,5-Anhydro-1,6-di-O-benzoyl-3-O-(hepta-O-acetyl-
b-D-maltosyl)-D-mannitol(21)
Prepared according to the general procedure C and D
from 26 (0.54 g, 1.1 mmol) to give 27 (1.75 g, 95%),
[a]D +7 (c 1, water); 1H NMR: d 4.97 (d, 1H,
Prepared according to the general procedure A from 4
(6.5 g, 17.5 mmol) and 20 (12.5 g, 18.4 mmol) to yield
after column chromatography (B) 21 as a syrup (5.6 g,
30%), Rf 0.4; [a]D +65 (c 1, CHCl3). Anal. Calcd for
C46H54O240: C, 55.76; H, 5.49. Found: C, 55.89; H, 5.62.
J1 ,2 = 7.4 Hz, H-100), 4.91 (t, 1H, J3,4 = J4,5 = 4 Hz,
00 00
H-4), 4.83 (d, 1H J1 ,2 = 6.3, H-10), 4.76 (t, 1H,
0
0
= 8.7 Hz, H-40) 4.69 (t, 1H, J2 ,3
=
0
J3 ,4
0
0
0
00 00
=
J4 ,5
J3 ,4 = 8.3 Hz, H-300), 4.61 (t, 1H, J2,3 = 4 Hz, H-3),
4.59 (t, 1H, J2,3 = 4 Hz, H-30) 4.53 (m, 2H, H-5,600)
4.47–4.00 (m, 11H), 3.90 (m, 1H, H-50); 13C NMR: d
104.1 (C-100), 103.1 (C-10), 86.4 (C-3), 84.6 (C-4), 83.2
(C-5), 82.6 (C-2), 80.7 (C-30), 79.9 (C-300), 79.6 (C-200),
79.3 (C-20), 76.7 (C-50), 76.4 (C-400), 76.0 (C-40) 75.5
(C-500), 71.1 (C-60), 70.4 (C-6), 70.0 (C-1), 70.1 (C-600).
Anal. Calcd for C18H22O45S10K10: C, 12.90; H, 1.32;
S, 19.18; K, 23.38. Found: C, 12.59; H, 1.89; S, 18.33;
K, 21.08.
00 00
1.20. 2,5-Anhydro-3-O-(b-D-maltosyl)-D-mannitol(22)
Prepared according to the general procedure B from 21
(1.6 g, 1.6 mmol) to give 22 (0.75 g, 95%) as an
amorphous powder, [a]D +96 (c 1, water). Anal. Calcd
for C18H32O15: C, 44.26; H, 6.60. Found: C, 44.08; H,
6.82.
1.21. 2,5-Anhydro-1,4,6-tri-O-sulfato-3-O-[4-O-(2,3,4,6-
tetra-O-sulfato-a-D-glucopyranosyl)-2,3,6-tri-O-sulfato-
b-D-glucopyranosyl]-D-mannitoldeca potassium satl (23)
1.25. 2,5-Anhydro-1,6-di-O-trityl-D-mannitol(28)
To a stirred soln of crude 2,5-anhydro-D-mannitol11,14
(4.6 g, 28 mmol) in pyridine (50 mL), TrCl (23 g,
70 mmol) was added and the mixture was stirred for
2 days at 20 ꢁC. Thereafter, it was poured into water, ex-
tracted with CH2Cl2, washed with M H2SO4, water, 5%
NaHCO3 and water, dried and concentrated. The semi-
crystalline residue (26 g) was purified by column chroma-
tography using first 1:5 EtOAc–hexane for removing the
by-products (Rf 0.9; 0.7 and 0.5) and then EtOAc for
eluting the product. Concentration of this latter fraction
gave 28 (13.2 g, 74%), Rf 0.5 (B); [a]D +14 (c 1, pyridine)
as solid foam, which was used without further
Prepared according to the general procedure C and D
from 22 (0.6 g, 1.2 mmol) to give 23 (1.95 g, 95%),
[a]D +33 (c 1, water); 1H NMR: d 5.59 (d, 1H,
J1 ,2 = 3.1 Hz, H-100), 5.04 (d, 1H, J1 ,2 = 5.3 Hz, H-
00 00
0
0
10), 4.95 (s, 1H, H-4), 4.86 (t, 1H, J2 ,3 = J3 ,4 = 8 Hz,
00 00
00 00
H-300) 4.75 (t, J2 ,3 = 5 Hz, H-20), 4.58 (s, 1H, H-3),
0
0
13
4.56–4.03 (m, 16H); C NMR: d 103.7 (C-10), 97.3
(C-100), 86.8 (C-3), 84.8 (C-4), 84.5, 83.5 (C-2,5), 79.9
(C-20), 79.4 (C-200), 77.7, 76.5, 76.2, 76.1, 74.9 (C-40,
C-50, C-300, C-400, C-500), 70.2, 70.0, 69.8, 68.9 (C-